1 King William Street

London EC4N 7AF


Tel:  0203-858-8185

Fax: 0203-858-8188

  • GBX Events
  • Gbx Events (Summit) You Tube
  • Gbx Events (Summit) Twitter

© 2019 by GBX. Proudly created with GBX Events Ltd.
Company Number: 11782795 - VAT: 317674779 UK

Cell & Gene Therapy Innovation Speaker

Katherine Seidl

Director, Oncology

Dr. Katherine Seidl earned a Ph.D. in Genetics (1996) from Stanford University, under the supervision of Drs. Len and Lee Herzenberg studying B cell development and immunoglobulin repertoire. After postdoctoral training at Harvard Medical School (1996-2000) under the guidance of Dr. Frederick Alt studying B cell immunoglobulin VDJ and class switch recombination, Dr. Seidl embarked on a 15+ year career in drug discovery and development. Since June 2016, Dr. Seidlhas served as Director, Oncology, at bluebird bio, Cambridge, MA. Dr. Seidl was formerly with Novartis Institute of Biomedical Research in Basel, Switzerland and Cambridge, MA , USA where she held several positions with increasing responsibility over a nearly 6 year tenure.